WHO ICTRP trial
Comparison of Oliceridine and Hydromorphone for Nausea and Vomiting in…
ChiCTR2500113933 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2500113933 |
|---|---|
| Public title | Comparison of Oliceridine and Hydromorphone for Nausea and Vomiting in Patient-Controlled Intravenous Analgesia After Orthopedic Surgery Under Multimodal Analgesia: A Prospective Cohort Study |
| Scientific title | Gastrointestinal Tolerability of the G Protein-Biased Agonist Oliceridine Versus Hydromorphone: A Prospective Cohort Study in Acute Postoperative Pain |
| Primary sponsor | The Second Affiliated Hospital, Zhejiang University School of Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Acute Pain |
| Interventions | Control group:After the surgery, 1 mg of hydromorphone and 10 mg of hydromorphone with 10 mg of tropisetron were administered, diluted with saline to 100 ml. The solution was infused through a intravenous analgesic pump at a rate of 1 ml/h… |
| Registration date | Dec 4, 2025 |
| Target size | Control group:108;Experimental group:108 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: